scholarly journals A lobulated mass on the upper back with prominent vasculature: A giant basal cell carcinoma

2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Elysha M. Kolitz ◽  
Brian L. Scott ◽  
Travis Vandergriff ◽  
Melissa Mauskar
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Cutaneous Lesion ◽  
Metastatic Potential ◽  
Deficiency Anemia ◽  
Invasive Growth ◽  
Significant Morbidity ◽  
Skin Cancers ◽  
Giant Basal Cell Carcinoma

Basal cell carcinoma (BCC) is characterized by slow but locally invasive growth. Although there is low metastatic potential, if not treated early, these skin cancers can lead to significant morbidity and mortality. In this case report, we present a man with a neglected BCC that developed into what is termed a giant BCC or one that is greater than 5 cm. This tumor was discovered only upon workup of orthostatic lightheadedness and iron deficiency anemia. Although rare, basal cell carcinoma must be included on the differential of a large cutaneous lesion and may be a source of significant blood loss.

scholarly journals Symptomatic iron deficiency anemia from neglected giant basal cell carcinoma

2020 ◽  
Vol 6 (10) ◽  
pp. 1019-1023
Author(s):  
Leah Laageide ◽  
Elizabeth Wendl ◽  
Jonathan Wadle ◽  
Jennifer Powers
Keyword(s):  
Iron Deficiency ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Iron Deficiency Anemia ◽  
Basal Cell ◽  
Deficiency Anemia ◽  
Giant Basal Cell Carcinoma

Two Cases of Giant Basal Cell Carcinoma of the Vulva

2005 ◽  
Vol 67 (6) ◽  
pp. 584-589 ◽  
Author(s):  
Tadamasa YAMAMOTO ◽  
Sachiko TAKEICHI ◽  
Daisuke FUKUMOTO ◽  
Hirotsugu TAKIWAKI ◽  
Seiji ARASE ◽  
...  
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Giant Basal Cell Carcinoma

Giant basal cell carcinoma: clinical–histological characteristics of 115 cases

2019 ◽  
Vol 58 (12) ◽  
pp. 1430-1434 ◽  
Author(s):  
Martha R. Vaca‐Aguilera ◽  
Elizabeth Guevara‐Gutiérrez ◽  
Juan G. Barrientos‐García ◽  
Alberto Tlacuilo‐Parra
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Histological Characteristics ◽  
Giant Basal Cell Carcinoma

scholarly journals Concurrent primary and secondary myiasis on basal cell carcinoma

2012 ◽  
Vol 87 (2) ◽  
pp. 292-295 ◽  
Author(s):  
Adriana Andrade Raposo ◽  
Antônio Pedro Mendes Schettini ◽  
Cesare Massone
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Histopathological Examination ◽  
Traumatic Injury ◽  
Skin Condition ◽  
Healthy Patient ◽  
Dorsal Region ◽  
Skin Cancers ◽  
Fly Larvae

Myiasis is a disease caused by infestation of fly larvae in human and other vertebrate tissues. It is a skin condition common in tropical and subtropical countries and its predisposing factors are: chronic diseases, immunodeficiency, poor hygiene, senility, psychiatric disorders, skin cancers and ulcerated mucosae. We report the case of a healthy patient who after traumatic injury of a preexisting lesion showed a tumor on the dorsal region parasitized by fly larvae. The histopathological examination performed for the diagnosis of skin neoplasm surprisingly revealed the presence of a partially degenerated larva with characteristics of Dermatobia hominis, suggesting an association of primary and secondary myiasis on basal cell carcinoma.

Giant basal cell carcinoma affecting the lower abdominal, genital and bilateral inguinal regions

2002 ◽  
Vol 55 (5) ◽  
pp. 445-448 ◽  
Author(s):  
Mamoru Kikuchi ◽  
Kenji Yano ◽  
Tateki Kubo ◽  
Ko Hosokawa ◽  
Yuji Yamaguchi ◽  
...  
Keyword(s):  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Giant Basal Cell Carcinoma

Giant Basal Cell Carcinoma of the Forehead with Extensive Intracranial Involvement

2007 ◽  
Vol 116 (9) ◽  
pp. 663-666 ◽  
Author(s):  
Ilka Charlotte Naumann ◽  
Susan R. Cordes
Keyword(s):  
Skin Lesion ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Basal Cell ◽  
Growth Pattern ◽  
Cancer Surveillance ◽  
Review Of The Literature ◽  
Intracranial Involvement ◽  
Malignant Skin ◽  
Giant Basal Cell Carcinoma

Basal cell carcinoma (BCC) is the most common malignant skin lesion and is frequently curatively treated with local excision. Improper removal or neglect of BCC is a particular problem for head and neck surgeons. We describe a case of a recurrent BCC that aggressively grew from the forehead skin through the skull and into the frontal lobe. We also present a review of the literature. Despite its fairly benign growth pattern, BCC should never be underestimated, and care should be taken not only in the complete primary excision but also in cancer surveillance.

Multifokale Neoplasien der Haut: Biologie, Ätiologie und zielgerichtete Therapien von nicht-melanozytärem Hautkrebs

2018 ◽  
Vol 6 (3) ◽  
pp. 135-146
Author(s):  
Ana R. Fernandes ◽  
Ana C. Santos ◽  
Elena Sanchez-Lopez ◽  
Andjekla B. Kovačević ◽  
Marta Espina ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Basal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Basal Cell ◽  
Photodynamische Therapie ◽  
Zielgerichtete Therapien ◽  
Aktinische Keratose ◽  
Skin Cancers ◽  
Nonmelanoma Skin Cancers

Neoplastische Hautläsionen sind multifokal auftretende, diffuse Hautinfiltrationen, die besonders in der Differentialdiagnose ulzerativer, nodulärer oder verkrustender Hautläsionen von Bedeutung sind. Nicht-melanozytäre Hautkrebsformen (nonmelanoma skin cancers, NMSC) wie das Basalzellkarzinom (basal cell carcinoma, BCC), das Plattenepithelkarzinom (squamous cell carcinoma, SCC) und die aktinische Keratose (AK) sind die häufigsten malignen Tumoren beim Menschen. BCC wachsen langsam und bilden meist keine Metastasen, wohingegen SCC ein stärker infiltrierendes, destruierendes Wachstum zeigen und Metastasen bilden. AK sind Vorstufen des kutanen SCC. Bei der klassischen NMSC-Therapie kommt die photodynamische Therapie in Verbindung mit Chemotherapeutika zur Anwendung. Das zunehmende Verständnis der Pathomechanismen, die bei der Tumorentstehung, -progression und -differenzierung eine Rolle spielen, stützt die Anwendung zielgerichteter Chemotherapien zur Verringerung der Zytotoxizität klassischer Therapien. Die vorliegende Übersichtsarbeit beschreibt den aktuellen Wissensstand über NMSC, einschließlich der Risikofaktoren, Onkogene und Karzinogenese von Hautkrebs und erörtert die herkömmliche Behandlung im Vergleich zu neuartigen therapeutischen Optionen. Übersetzung aus Skin Pharmacol Physiol 2018;31:59-73 (DOI: 10.1159/000479529)

Sign in / Sign up

Export Citation Format

Share Document